Cargando…

Coexistence Of A Huge Venous Thromboembolism And Bleeding Tendency In Cytokine Release Syndrome During CAR-T Therapy

Chimeric antigen receptor (CAR)-modified T cell therapy is increasingly administered for hematological malignancies. Cytokine release syndrome (CRS) is a common and severe complication of CAR-T therapy. In the present case, a 62-year-old male patient was diagnosed with relapsed and refractory multip...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Haiyan, Yang, Ye, Jiang, Jie, Wang, Xinfeng, Zhang, Chenlu, Jiang, Yijing, Hong, Lemin, Huang, Hongming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826178/ https://www.ncbi.nlm.nih.gov/pubmed/31802905 http://dx.doi.org/10.2147/OTT.S223697

Ejemplares similares

The Prognostic Role of Cyclin D1 in Multiple Myeloma: A Systematic Review and Meta-Analysis
por: Jiang, Yuwen, et al.
Publicado: (2022)

Entire ABL1 Gene Deletion Without BCR/ABL1 Rearrangement in a Female Patient with B-Cell Precursor Acute Lymphoblastic Leukemia
por: Jiang, Yijing, et al.
Publicado: (2020)

Type 2 diabetes mellitus does not increase the risk of multiple myeloma: a systematic review and meta-analysis
por: Zhang, Chenlu, et al.
Publicado: (2020)

lncRNA transcription factor 7 is related to deteriorating clinical features and poor prognosis in multiple myeloma, and its knockdown suppresses disease progression by regulating the miR-203-mediated Jagged1-Notch1 signaling pathway
por: Liu, Haiyan, et al.
Publicado: (2021)

Venous thromboembolism and sarcoidosis: co-incidence or coexistence?
por: Goljan-Geremek, Anna, et al.
Publicado: (2016)

ANXA7 promotes the cell cycle, proliferation and cell adhesion-mediated drug resistance of multiple myeloma cells by up-regulating CDC5L
por: Liu, Haiyan, et al.
Publicado: (2020)

Bleeding risk assessment for venous thromboembolism prophylaxis
por: Chindamo, Maria Chiara, et al.
Publicado: (2021)

Contrasts in Glioblastoma—Venous Thromboembolism versus Bleeding Risk
por: Muster, Viktoria, et al.
Publicado: (2021)

Biomarkers of bleeding and venous thromboembolism in patients with acute leukemia
por: Hisada, Yohei, et al.
Publicado: (2023)

Risk assessment of venous thromboembolism and bleeding in COVID‐19 patients
por: Wang, Lan, et al.
Publicado: (2022)

Bleeding outcomes in thrombocytopenic acute leukemic patients with venous thromboembolism
por: Wilson, Nathaniel R., et al.
Publicado: (2020)

Evaluation of the predictive value of the bleeding prediction score VTE‐BLEED for recurrent venous thromboembolism
por: Klok, Frederikus A., et al.
Publicado: (2019)

Symptomatic Venous Thromboembolism Is a Disease Related to Infection and Immune Dysfunction
por: Duan, Qianglin, et al.
Publicado: (2012)

Paradoxical massive pulmonary thromboembolism in a postpartum woman with factor VII deficiency with bleeding tendency: A case report
por: Kang, Donghoon, et al.
Publicado: (2022)

Prediction of Major Bleeding in Anticoagulated Patients for Venous Thromboembolism: Comparison of the RIETE and the VTE-BLEED Scores
por: Lecumberri, Ramón, et al.
Publicado: (2021)

Coexistence of Antiphospholipid Syndrome and Heparin-Induced Thrombocytopenia in a Patient with Recurrent Venous Thromboembolism
por: Adediran, Samuel, et al.
Publicado: (2017)

The High Expression of Adhering and Circulating Integrin Serves as a Diagnostic Marker in Venous Thromboembolism
por: Yang, Fan, et al.
Publicado: (2022)

COVID-19–associated venous thromboembolism: risk of recurrence and major bleeding
por: Demelo-Rodriguez, Pablo, et al.
Publicado: (2023)

Impact of a Program to Improve Venous Thromboembolism Prophylaxis on Incidence of Thromboembolism and Bleeding Rates in Hospitalized Patients During Implementation of Programs to Improve Venous Thromboembolism Prophylaxis
por: Lovely, Jenna K., et al.
Publicado: (2020)

Incidence of Venous Thromboembolism in Multiple Myeloma Patients across Different Regimens: Role of Procoagulant Microparticles and Cytokine Release
por: Gidaro, Antonio, et al.
Publicado: (2022)

Thrombomodulin in patients with mild to moderate bleeding tendency
por: Mehic, Dino, et al.
Publicado: (2021)

The Dysprothrombinemias due to Arg596 Mutations: A Conundrum With No Bleeding Tendency and Venous Thrombosis due to Antithrombin Resistance
por: Girolami, Antonio, et al.
Publicado: (2019)

Cytokines Are at the Heart of It: Cytokine Release Syndrome Underlies Cardiovascular Effects of CAR T Cell
por: Catino, Anna B.
Publicado: (2020)

Circ-SMARCA5 suppresses progression of multiple myeloma by targeting miR-767-5p
por: Liu, Haiyan, et al.
Publicado: (2019)

Longitudinal Evaluation of Health Plan Cost per Venous Thromboembolism or Bleed Event in Patients With a Prior Venous Thromboembolism Event During Hospitalization
por: Bullano, Michael F., et al.
Publicado: (2005)

D-Dimer Measured at Diagnosis of Venous Thromboembolism is Associated with Risk of Major Bleeding
por: Johnsen, Håkon S., et al.
Publicado: (2019)

Bleeding risk in patients with venous thromboembolic events treated with new oral anticoagulants
por: Wallvik, Niklas, et al.
Publicado: (2020)

Bleeding in women with venous thromboembolism during pregnancy: A systematic review of the literature
por: Simard, Camille, et al.
Publicado: (2022)

Incidence and clinical impact of bleeding events in older patients with acute venous thromboembolism
por: Ferrazzini, Elisa, et al.
Publicado: (2022)

Recurrent venous thromboembolism and bleeding with extended anticoagulation: the VTE-PREDICT risk score
por: de Winter, Maria A, et al.
Publicado: (2023)

Assessment of bleeding risk in cancer patients treated with anticoagulants for venous thromboembolic events
por: Poénou, Géraldine, et al.
Publicado: (2023)

Hemofiltration Successfully Eliminates Severe Cytokine Release Syndrome Following CD19 CAR-T-Cell Therapy
por: Liu, Yanfen, et al.
Publicado: (2018)

Thromboembolic tendency (TE) in IBD (inflammatory bowel disease) patients
por: Canero, A, et al.
Publicado: (2010)

Sertraline-Related Bleeding Tendency: Could It Be Dose-Dependent?
por: Eslami Shahrbabki, Mahin, et al.
Publicado: (2014)

Diagnostic work up of patients with increased bleeding tendency
por: Zegers, Suzanne A. M., et al.
Publicado: (2019)

Triple emergencies: Hyperosmolar hyperglycemic state, venous thromboembolism, and huge free‐floating right heart thrombus successfully managed with anticoagulation
por: Umar, Hayatu, et al.
Publicado: (2021)

The Mutation of BTG2 Gene Predicts a Poor Outcome in Primary Testicular Diffuse Large B-Cell Lymphoma
por: Guo, Dan, et al.
Publicado: (2022)

Open carpal release using local anesthesia without a tourniquet: Does bleeding tendency affect the outcome?
por: Lee, Seongwon, et al.
Publicado: (2020)

Recurrent thromboembolism, bleeding, and mortality in Asian patients with venous thromboembolism receiving different oral anticoagulants: A nationwide analysis
por: Lee, Mei-Chuan, et al.
Publicado: (2022)

Venous thromboembolism /
por: Hirsh, Jack, 1935-
Publicado: (1981)

Cannot write session to /tmp/vufind_sessions/sess_otlfb0mvnsjngmqv1ik94870dq